COMPOSITION MULTIUSAGE DE TORASEMIDE

European patent · EP3752129 · In force

Register entry

Publication number
EP3752129
Application number
EP19710750
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 15, 2019
Published
Dec 23, 2020
Granted
Nov 24, 2021
Protection ends at the latest
Feb 14, 2039
Next annual fee due
Feb 28, 2027
IPC classes
A61K 9/08 (2006.01)
A61K 47/10 (2017.01)
A61K 47/18 (2017.01)
A61K 31/64 (2006.01)
A61P 9/12 (2006.01)
Priority
FR 1851353 16.02.2018
PCT application
PCT/FR2019/050345 15.02.2019
PCT publication
WO2019/158873 22.08.2019
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Mar 1, 2025

    Change

    Published in Swissreg on 01.03.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  5. Oct 5, 2022

    Change

    Published in Swissreg on 05.10.2022

  6. Feb 1, 2022

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 01.02.2022

  7. Nov 24, 2021

    Granted

    Published in Swissreg on 24.11.2021

Parties

Holder

VETOQUINOL SA

Vetoquinol SA

70200 Magny-Vernois, FR

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

MOREAU, Marinette

70200 SAINT-GERMAIN, FR

LEGO, Elodie

70200 LURE, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.